This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Effectiveness results
The stability of 20 mg/ml ganciclovir in saline was 20. 66, 20.34 and 20.36 at room temperature for 10, 17 and 24 days of storage, respectively. The corresponding figures were 20. 41, 20.25 and 20.24 at 5 degrees C., and 20.85, 20.41 and 20 .53 at -8 degrees C. The solubility of 20 mg/ml ganciclovir in saline was 19.93 if freshly prepared, 20.21 if freshly prepared and filtered, 20.18 if freshly prepared and heated at 56 degrees C., 20.21 if freshly prepared and filtered and heated, 20.41 if stored at -8 degrees C., and thawed at room temperature and 20.31 if stored at -8 degrees C., and heated at 56 degrees C for 30 minutes.
Clinical conclusions
There was little variation in the concentration of ganciclovir regardless of the storage conditions, suggesting that the 20 mg/ml solution was very stable. The heating and filtering experiments suggest that maximum solubility was achieved both in the freshly prepared and thawed frozen-stored solution.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the analysis and as such the benefits are considered to be the same as the outcome measures.
Direct costs
The costs measured were pharmacy costs as an approximation to staff, depreciation and disposable costs of preparing the injections and the fees for outpatient visits and injection procedure. The quantity/cost boundary adopted was the hospital. Resource quantities were reported separately from the prices. For the intervention, quantities were based on actual data, while costs were estimated using the standard charge for an outpatient visit by the hospital and the Commonwealth Medical Benefits Schedule (MBS). For the comparator, quantities were based on an estimate while unitary costs were obtained from the same sources as before. Discounting was not undertaken. The price year was not stated.
Statistical analysis of costs
Not undertaken.
Currency
Australian dollars (Aus$).
Sensitivity analysis
No sensitivity analysis was performed.
Estimated benefits used in the economic analysis
The stability of 20 mg/ml ganciclovir in saline was 20. 66, 20.34 and 20.36 at room temperature for 10, 17 and 24 days of storage, respectively. The corresponding figures were 20. 41, 20.25 and 20.24 at 5 degrees C and 20.85, 20.41 and 20 .53 at -8 degrees C. The solubility of 20 mg/ml ganciclovir in saline was 19.93 if freshly prepared, 20.21 if freshly prepared and filtered, 20.18 if freshly prepared and heated at 56 degrees C., 20.21 if freshly prepared and filtered and heated, 20.41 if stored at -8 degrees C., and thawed at room temperature and 20.31 if stored at -8 degrees C., and heated at 56 degrees C for 30 minutes.
